Guangyuyuan (600771.SH) released its half-year report on August 22nd. During the reporting period, the company achieved revenue of 0.66 billion yuan, a decrease of 4.90% compared to the same period last year. The net income attributable to shareholders listed on the stock market was 59.6031 million yuan, an increase of 13.75% year-on-year.
With the support of policy upgrades, the high-quality traditional Chinese medicine has increased efforts to empower the terminal and continuously strengthen investment in brand building. Participated in 4 national-level conferences and 46 highly targeted activities, and held more than 20 activities in various terminal stores. During the reporting period, the control policy was implemented for the first time. At the same time, based on the integration of the existing national medical halls, national pharmacies, and museums, the management system for high-quality products was reformed, the headquarters' control was strengthened, and flat management was implemented in various stores. As of June 30, 2024, 17 new agents had been hired, with a total of 415 terminal stores. During the reporting period, 128 new stores were added and 111 were optimized.
